News

20 August 2017
Popular immunotherapy target turns out to have a surprising buddy

The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. Researchers from the Netherlands Cancer Institute publish these findings in the leading journal Nature on August 16.  

15 June 2017
Albert Heck receives NWO Spinoza Prize

Today NWO president Stan Gielen announced that Utrecht University Professor Albert Heck has been awarded an NWO Spinoza Prize. Heck has been given this prize for his exceptional, pioneering and inspiring work. The NWO Spinoza Prize is the highest scientific distinction in the Netherlands. The laureates will each receive 2.5 million euros which they can spend on scientific research.

11 January 2017
Celia Berkers elected member KNAW Young Academy

Every year The Young Academy selects ten talented new researchers to add to its ranks. In addition to their proven research excellence, Young Academy members take a broad interest in science and in science communication. 

This year, Celia Berkers from the ICI and Utrecht University has been selected as a new KNAW Young Academy member for a five-year period. She will be inducted on 8 June 2017 in Amsterdam. 

21 November 2016
Heck_HonoryMembership
Albert Heck named Honorary Member of the Spanish Proteomics Society

Professor Albert Heck, Utrecht University and member of the ICI executive board, has received an honory membership of the Spanish Proteomics Society. Heck was honored during the Opening Ceremony of the 6th Congress of the Spanish Proteomics Society in Cadiz on November 15th 2016.

On the picture Heck receives the award from Angel García, President of the Spanish Proteomics Society.

27 July 2016
Prestigious award for Ton Schumacher

Ton Schumacher, ICI executive board member and group leader within the division of Immunology at the Netherlands Cancer Institute, has been named recipient of the 2016 William B. Coley Award. This prize is awarded yearly by the American Cancer Research Institute (CRI). It was instigated to honor scientists who have made highly important contributions to the field of cancer immunology.

25 April 2016
NVMS award for Albert Heck

The Dutch Society for Mass Spectrometry (NVMS) has honoured Albert Heck with the Outstanding Research Award 2016. Heck received the award for his many excellent contributions to the field of Mass Spectrometry. Heck is Professor of Biomolecular Mass Spectrometry and Proteomics at Utrecht University, and Scientific Director of the Netherlands Proteomics Centre and the large-scale research facility Proteins At Work.

25 February 2016
Collaboration Neon Therapeutics and NKI

The Netherlands Cancer Institute (NKI) together with the Amsterdam Biotherapeutics Unit has entered into a collaborative reseach agreement with Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer.

17 February 2016
2nd Chemical Immunology Conference - registration is now open!

On April 1, 2016, the second Chemical Immunology Conference of the Institute for Chemical Immunology will take place in the Rode Hoed in Amsterdam.

18 January 2016
Heck group in European programme to make large-scale protein analysis clinically applicable

Within five years, the first hospitals should be able to completely analyse all of the proteins in a patient’s blood and urine in order to provide more individualised treatment. That is the ambition of the researchers at Utrecht University and their four European partners. The researchers have received a 3.7 million Euro grant for their MSmed research proposal as part of the Future and Emerging Technologies programme within the Horizon 2020 project. On 14 and 15 January, MSmed officially kicked off its activities at an event in Copenhagen.

Pages